Functional dyspepsia. Dyspepsia
Conditions
Interventions
Intervention 1: Intervention group: The patients with positive H. pylori will receive a combination of bismuth subcitrate (3×500 mg), metronidazole (3×250 mg), amoxicillin (3×500 mg) and either omepra
Behavior
Treatment - Drugs
Intervention group: The patients with positive H. pylori will receive a combination of bismuth subcitrate (3×500 mg), metronidazole (3×250 mg), amoxicillin (3×500 mg) and either omeprazole (2×20 mg) (
Control group: The patients with positive H. pylori will receive a combination of bismuth subcitrate (3×500 mg), metronidazole (3×250 mg), amoxicillin (3×500 mg) and either omeprazole (2×20 mg) (2×150
Sponsors
Tarbiat Modares University
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women 20-40 and education diploma or above with normal test of endoscopy, sonography, and routine blood tests Exclusion criteria: Irritable bowel syndrome, Paranoid personality, Schizoid personality
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of functional dyspepsia. Timepoint: before and after treatment and 1 month after treatment. Method of measurement: Patient assessment of upper gastrointestinal disorder – symptom severity index,. | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychological symptoms. Timepoint: before tratment, after treatment, and 1 month after treatment. Method of measurement: ScL-90. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahbobeh Faramarzi
Babol University of Medical Sciences
Outcome results
None listed